THE 5-SECOND TRICK FOR TRASTUZUMAB MONITORING

[43] Moreover, trastuzumab suppresses angiogenesis both by induction of antiangiogenic components and repression of proangiogenic variables. It is assumed that a contribution for the unregulated advancement observed in cancer could possibly be as a result of proteolytic cleavage of HER2/neu that results in the discharge in the extracellular domain.